GRN163L

GRN163L is an experimental drug designed to target and inhibit an enzyme called telomerase, which is often active in cancer cells. Telomerase helps cancer cells keep dividing endlessly by maintaining their chromosome ends, called telomeres. By blocking this enzyme, GRN163L aims to limit the cancer cells' ability to multiply and grow. Although still under research, this approach offers a potential strategy for cancer treatment by disrupting the cellular mechanism that allows tumors to persist and expand.